HomeMarkets overviewSharesSyndax Pharmaceuticals, Inc.

Trade Syndax Pharmaceuticals, Inc. - SNDX CFD

Market is not available at the momentMarket information is presented
as of 2026-11-20T20:49:52+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.05
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02229 %
(-$0.45)

Trade size with leverage ~ $2,000.00

Money from leverage ~ $1,000.00


-0.02229%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.00007 %
($0.00)

Trade size with leverage ~ $2,000.00

Money from leverage ~ $1,000.00


0.00007%
Overnight funding adjustment time22:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin50.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close9.1
Open8.91
1-Year Change-46.45%
Day's Range8.7 - 9.18

Trade Syndax Pharmaceuticals, Inc. - SNDX

What is Syndax Pharmaceuticals, Inc. (SNDX)?

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for the treatment of cancer. The company primarily concentrates on epigenetic therapies and immuno-oncology, aiming to address unmet medical needs in oncology. Syndax's research and development efforts include the advancement of drug candidates that target specific molecular pathways involved in tumor growth and immune response modulation. The company collaborates with academic institutions and industry partners to support its clinical programs. Syndax Pharmaceuticals operates within the biotechnology sector and is engaged in the discovery, development, and potential commercialization of innovative cancer treatments. Its pipeline includes compounds designed to enhance the efficacy of existing therapies or provide new options for patients with various types of cancer. The company is headquartered in the United States and contributes to the broader field of oncology drug development through its focus on epigenetic and immune-based therapeutic approaches.

Syndax Pharmaceuticals, Inc. Stock Price Today: Live Overview

The price today is shaped by ongoing intraday activity, with Syndax Pharmaceuticals, Inc. at $8.79. It has fluctuated within the range of $8.86 to $9.22, reflecting a daily move of -2.1978%.

FAQ: Syndax Pharmaceuticals, Inc. (SNDX)

What is the current price of SNDX stock?

The last traded price is $8.79.

Does SNDX pay dividends?

Syndax Pharmaceuticals, Inc. does not pay dividends.

Does SNDX have a formal corporate presence or regional headquarters in the UAE?

Syndax Pharmaceuticals, Inc. does not maintain a regional office or subsidiary in the UAE and operates through partners.

What is SNDX best known for?

Syndax Pharmaceuticals, Inc. is most famous for developing cancer and immunology therapies.

What assets are typically shown together with SNDX?

Commonly shown alongside SNDX: Abu Dhabi Islamic Bank PJSC, Owens Corning, Zijin Mining

Latest shares articles

Take-Two heads into GTA VI launch with a weaker quarter and full-year outlook unchanged
Take-Two’s Q2 Net Bookings came in below guidance, but GTA VI pre-orders are at ‘unprecedented levels’. What the launch could mean for TTWO stock.
13:30, 19 November 2026
Nvidia stock forecast: Third-party price target
NVIDIA stock forecast: Q3 earnings, CEO transition
US semiconductor giant NVIDIA (NVDA) reported third-quarter fiscal 2027 revenue of $115.8bn on 17 November 2026, up 103% year on year. Explore third-party price targets and technical analysis. Past performance isn't a reliable indicator of future results.
13:40, 18 November 2026
Nvidia results preview: what to expect from Q3 after the AI sell-off
Revenue guidance of USD 108bn, a new interim CEO and an AI sell-off: what investors are watching as Nvidia reports its fiscal Q3 2027 results.
12:06, 17 November 2026
What you need to know about Alphabet after the biggest one-day drop in its history – break-down
Google Cloud is growing fast, but AI spending pushed Alphabet’s free cash flow negative. A full break-down of results, valuation, debt and risks for GOOGL
11:53, 13 November 2026

User feedback and ratings

2025-07-01
Victor Flemming Nandwa Søder

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-07-01
Perry Reineke

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-06-29
proinpro

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

2025-06-27
Gio Gvazava

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-27
Douglas

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-22
Jean A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-19
foobarbeer

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-06-19
Casaubon70

Love the TV integration. Makes traders life smooth and comfortable.

2025-06-19
dgogidze7

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-05-30
Brigman

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-05-24
Radioilluminati

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-05-20
GemzT

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
dmjnoor

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-03-24
Debbie P

The best trading company I've found so far and so easy to use.

2025-02-06
Nouman Butt

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

Showing our 4 & 5 star reviews.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready